147 related articles for article (PubMed ID: 31960941)
1. Uterine Leiomyoma with Massive Lymphoid Infiltrate in a Patient with History of Assisted In-Vitro Fertilization.
Prete MD; Collamarini M; Collamarini C; Sesti F; Mauriello A; Palmieri G
Turk Patoloji Derg; 2020; 36(3):251-255. PubMed ID: 31960941
[TBL] [Abstract][Full Text] [Related]
2. Unusual morphologic features of uterine leiomyomas treated with gonadotropin-releasing hormone agonists: massive lymphoid infiltration and vasculitis.
McClean G; McCluggage WG
Int J Surg Pathol; 2003 Oct; 11(4):339-44. PubMed ID: 14615835
[TBL] [Abstract][Full Text] [Related]
3. Leiomyoma With Massive Lymphoid Infiltration: 2 Cases With Lymphocytic Vasculopathy and Angiocentric Germinal Centers.
Wong J; Roy SF; Provencher D; Maietta A; Rahimi K
Int J Gynecol Pathol; 2023 Mar; 42(2):155-158. PubMed ID: 35348475
[TBL] [Abstract][Full Text] [Related]
4. Uterine leiomyoma with massive lymphoid infiltration: case report and review of the literature.
Paik SS; Oh YH; Jang KS; Han HX; Cho SH
Pathol Int; 2004 May; 54(5):343-8. PubMed ID: 15086839
[TBL] [Abstract][Full Text] [Related]
5. Uterine leiomyomas with lymphoid infiltration simulating lymphoma. A report of seven cases.
Ferry JA; Harris NL; Scully RE
Int J Gynecol Pathol; 1989; 8(3):263-70. PubMed ID: 2670790
[TBL] [Abstract][Full Text] [Related]
6. [Uterine leiomyoma with massive lymphoid infiltration: case report].
Zouari IB; Gouiaa N; Charfi S; Ellouze S; Chaari C; Kessentini M; Hssini A; Boudawara TS
Ann Pathol; 2011 Apr; 31(2):98-101. PubMed ID: 21601114
[TBL] [Abstract][Full Text] [Related]
7. Frequency, histological, and immunohistochemical properties of massive inflammatory lymphocytic infiltration of leiomyomas of the uterus: an entity causing diagnostic difficulties.
Botsis D; Koliopoulos C; Kondi-Pafitis A; Creatsas G
Int J Gynecol Pathol; 2005 Oct; 24(4):326-9. PubMed ID: 16175076
[TBL] [Abstract][Full Text] [Related]
8. Uterine leiomyoma with prominent lymphoid infiltrate.
Sağlam A; Güler G; Taşkin M; Ayhan A; Uner AH
Int J Gynecol Cancer; 2005; 15(1):167-70. PubMed ID: 15670313
[TBL] [Abstract][Full Text] [Related]
9. Uterine leiomyoma with massive lymphocytic infiltration simulating malignant lymphoma. A case report with immunohistochemical study showing that the infiltrating lymphocytes are cytotoxic T cells.
Chuang SS; Lin CN; Li CY; Wu CH
Pathol Res Pract; 2001; 197(2):135-8. PubMed ID: 11261818
[TBL] [Abstract][Full Text] [Related]
10. Enhanced deoxyribonucleic acid damage and repair but unchanged apoptosis in uterine leiomyomas treated with gonadotropin-releasing hormone agonist.
Huang SC; Chou CY; Lin YS; Tsai YC; Hsu KF; Liu CH; Huang KE
Am J Obstet Gynecol; 1997 Aug; 177(2):417-24. PubMed ID: 9290461
[TBL] [Abstract][Full Text] [Related]
11. Massive lymphocytic infiltration of uterine leiomyomas associated with GnRH agonist treatment.
Bardsley V; Cooper P; Peat DS
Histopathology; 1998 Jul; 33(1):80-2. PubMed ID: 9726054
[TBL] [Abstract][Full Text] [Related]
12. Uterine myoma with massive lymphocytic infiltration - case report.
Wasyluk T; Obrzut B; Gałązka K; Żmuda M; Obrzut M; Darmochwał-Kolarz D
Prz Menopauzalny; 2019 Jun; 18(2):123-125. PubMed ID: 31485209
[TBL] [Abstract][Full Text] [Related]
13. The histopathology of uterine leiomyomas following treatment with gonadotropin-releasing hormone analogues.
Colgan TJ; Pendergast S; LeBlanc M
Hum Pathol; 1993 Oct; 24(10):1073-7. PubMed ID: 8406417
[TBL] [Abstract][Full Text] [Related]
14. Unexpected pulmonary tumor: metastasis from a benign uterine leiomyoma in a post-menopausal woman: a case report.
Efared B; Atsame-Ebang G; Sani R; Tahiri L; Sidibe IS; Erregad F; Hammas N; Smahi M; Serraj M; Chbani L; Fatemi HE
BMC Res Notes; 2017 Dec; 10(1):662. PubMed ID: 29191211
[TBL] [Abstract][Full Text] [Related]
15. Leiomyoma of the uterus with massive lymphoid infiltration simulating lymphoma. A case report.
Botsis D; Trakakis E; Kondis-Pafitis A; Kontoravdis A; Kassanos D; Chryssikopoulos A; Creatsas G
Eur J Gynaecol Oncol; 1999; 20(1):61-2. PubMed ID: 10422685
[No Abstract] [Full Text] [Related]
16. Mesenchymal tumors of the uterine corpus with heterologous and hematopoietic components: a study of ten cases and review of the literature.
Kondi-Pafiti A; Grapsa D; Kairi-Vassilatou E; Kontogianni-Katsarou K; Koliopoulos C; Botsis D
Eur J Gynaecol Oncol; 2006; 27(1):73-7. PubMed ID: 16550975
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: the estrogen threshold hypothesis.
Friedman AJ; Lobel SM; Rein MS; Barbieri RL
Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 1):1114-9. PubMed ID: 2145765
[TBL] [Abstract][Full Text] [Related]
18. Morphometric and electron-microscopic analyses of the effects of gonadotropin-releasing hormone agonists on uterine leiomyomas.
Kalir T; Goldstein M; Dottino P; Brodman M; Gordon R; Deligdisch L; Wu H; Gil J
Arch Pathol Lab Med; 1998 May; 122(5):442-6. PubMed ID: 9593346
[TBL] [Abstract][Full Text] [Related]
19. Uterine leiomyomas with T-cell infiltration associated with GnRH agonist goserelin.
Laforga JB; Aranda FI
Histopathology; 1999 May; 34(5):471-2. PubMed ID: 10231516
[No Abstract] [Full Text] [Related]
20. Shrinkage effect of gonadotropin releasing hormone agonist treatment on uterine leiomyomas and t(12;14).
Takahashi K; Kawamura N; Ishiko O; Ogita S
Int J Oncol; 2002 Feb; 20(2):279-83. PubMed ID: 11788889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
